Last reviewed · How we verify
Placebo Matrix/CHADD Patch
The Placebo Matrix/CHADD Patch does not contain an active pharmaceutical ingredient and is used as a control in clinical trials.
At a glance
| Generic name | Placebo Matrix/CHADD Patch |
|---|---|
| Also known as | Placebo patch with heating system |
| Sponsor | ZARS Pharma Inc. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
It is designed to mimic the appearance and application process of an active patch to maintain blinding in placebo-controlled studies, ensuring that the psychological impact of treatment can be isolated from pharmacological effects.
Approved indications
Common side effects
Key clinical trials
- Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee (PHASE2)
- Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain (PHASE2)
- Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Matrix/CHADD Patch CI brief — competitive landscape report
- Placebo Matrix/CHADD Patch updates RSS · CI watch RSS
- ZARS Pharma Inc. portfolio CI